Garry Arthur Neil - Dec 10, 2021 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Chief Scientific Officer
Signature
/s/ Michael McInaw, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Dec 10, 2021
Transactions value $
$6,699
Form type
4
Date filed
12/14/2021, 04:15 PM
Previous filing
Jun 15, 2021
Next filing
Mar 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $6.7K +4.27K +5.24% $1.57 85.6K Dec 10, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.